Mesangial cell proliferation is common in glomerulonephritis but it is unclear if proliferation is associated with any in vivo alteration in phenotype. We investigated whether mesangial cells acquire smooth muscle-like characteristics in a rat model of mesangial proliferative nephritis induced with antibody to the Thy-i antigen present on mesangial cells. At day 3 glomeruli displayed de novo immunostaining for a-smooth muscle actin in a mesangial pattern, correlating with the onset of proliferation, and persisting until day 14. An increase in desmin and vimentin in mesangial regions was also noted. Immunoelectron microscopy confirmed that the actin-positive cells were mesangial cells, and double immunolabeling demonstrated that the smooth muscle actin-positive cells were actively proliferating. Northern analysis of isolated glomerular RNA confirmed an increase in a and #/-y actin mRNA at days 3 and 5. Complement depletion or platelet depletion prevented or reduced proliferation, respectively; these maneuvers also prevented smooth muscle actin and actin gene expression. Studies of five other experimental models of nephritis confirmed that smooth muscle actin expression is a marker for mesangial cell injury. Thus, mesangial cell proliferation in glomerulonephritis in the rat is associated with a distinct phenotypic change in which mesangial cells assume smooth muscle cell characteristics. (J. Clin. Invest. 1991. 87:847-858.)
Introduction
The mesangial cell may have diverse functions. The mesangial cell provides structural support to the glomerulus via production of extracellular matrix components to form the mesangial matrix (reviewed in references 1-3). The mesangial cell may function as a proinflammatory effector cell, similar to the monocyte/macrophage, as in vitro studies have demonstrated that the mesangial cell is phagocytic, and is also capable of releasing oxidants, a basement membrane-degrading proteinase, prostaglandins, and cytokines including interleukin-1, tu-mor necrosis factor, interleukin-6, and platelet-derived growth factor (1) (2) (3) (4) (5) (6) (7) (8) (9) . Mesangial cells also morphologically resemble smooth muscle cells in culture and can be shown to be contractile, a function that may modulate glomerular hemodynamics by controlling glomerular capillary surface area (2, 3) .
The pathogenetic mechanisms for progressive glomerular injury in immune complex nephritis have been classically ascribed to the action of antibody, complement, and/or infiltrating leukocytes. Recently, a role for the mesangial cell in glomerular injury has been proposed, in which the mesangial cell has been hypothesized to become "activated" and assumes a proinflammatory phenotype as described in vitro (1) (2) (3) (4) (5) (6) (7) (8) (9) . The glomerular diseases in which mesangial cells may be actively involved would likely include IgA nephropathy, membranoproliferative GN, variants of minimal change disease, and focal sclerosis; these are diseases in which mesangial cell proliferation is commonly observed. However, an increase in mesangial cell number does not necessarily mean that the mesangial cells have undergone a change in phenotype. Indeed, studies ofmesangial cells in culture have failed to demonstrate a correlation between proliferative activity and the ability to acquire an "activated" phenotype, as demonstrated by the ability of the mesangial cell to release neutral proteinase or type IV collagen (10) .
In this paper, we demonstrate that mesangial cells undergo phenotypic alteration in a rat model of mesangial proliferative glomerulonephritis (GN).' Specifically, mesangial cells acquire smooth muscle-like characteristics, with the de novo expression of a-smooth muscle actin protein, as well as increased expression of the type III intermediate filament proteins, desmin and vimentin. Both the a-smooth muscle gene and protein expression are associated with active cell proliferation and can be inhibited in rats in which proliferation was prevented by complement or platelet depletion. Finally, studies of five other models of GN demonstrate that the expression of a-smooth muscle actin is present only in those diseases associated with mesangial cell injury. Thus, a-smooth muscle actin is a marker of mesangial cell activation in GN in the rat.
Methods

Experimental protocol
Studies were performed to examine the expression ofactin and the type III intermediate filament proteins, desmin and vimentin, in mesangial proliferative GN in the rat induced with anti-Thy I antibody. This model is associated with severe mesangiolysis (defined as dissolution of mesangial matrix with loss of mesangial cells [ 1l]) followed by mesangial cell proliferation (12) . Whereas the mesangial cell proliferation requires the presence of both complement (13) and platelets (14) , the mesangiolysis is dependent only on complement (13) .
Six groups of Wistar rats (Simonsen Laboratories, Gilroy, CA) (n = 6 in each group) were studied: (a) normal unmanipulated rats, (b-d) rats with anti-Thy I GN at 1, 3, and 5 d after disease induction, and (e-f) rats with anti-Thy 1 GN (day 3) that were either complement-depleted or platelet-depleted.
For each group ofrats, biopsies were taken for histologic studies and then the rats were sacrificed, glomeruli isolated, and RNA extracted (see below). Actin expression was determined immunohistochemically with a panel of four monoclonal anti-actin antibodies, and actin mRNA was measured in glomerular RNA extracts by Northern analysis using a cDNA probe for the #/'y actin mRNA and with an oligonucleotide probe specific for a smooth muscle actin mRNA. Vimentin and desmin were also studied by immunohistochemistry on tissue sections with specific monoclonal antibodies (see below). These studies were correlated with the severity ofthe mesangiolysis and the degree of proliferation in each group (see below).
Additional studies included the determination of actin expression (immunohistochemically) in rats with anti-Thy 1 GN at days 8, 14, and 21 after disease induction, as well as actin expression in rats with five different experimentally-induced glomerular diseases (n = 2 in each group). To control for the possibility that the antiplatelet IgG could independently affect actin, desmin, or vimentin expression, antiplatelet IgG was administered to four normal rats, and kidneys were biopsied at 3 d for immunohistochemical studies.
Disease models
Anti-Thy 1 GN. Antithymocyte serum (ATS) was raised in a goat with repeated immunizations of Lewis rat thymocytes as previously described (14) . An intravenous dose of 0.4 ml plasma/100 g body weight was used to induce disease.
Other models. OtherGN models studied included diseases predominantly affecting: (a) the glomerular epithelial cell (i.e., aminonucleoside nephrosis and passive Heymann nephritis), (b) the glomerular basement membrane (GBM) (i.e., heterologous anti-GBM GN); (c) the mesangial cell (i.e., Habu snake venom GN), and (d) both the endothelial cell and mesangial cell (i.e., GN induced with concanavalin A (con A) and anti-con A antibody). The methods used to establish these diseases have been previously published (15, 16) , and were not modified with the exception of Habu snake venom GN, in which the rats received a single i.v. dose of Habu snake venom (2 mg) (Quality Venoms, Punta Gorda, FL).
Quantitation ofproliferation and mesangiolysis
For each biopsy, 20 glomeruli were sequentially examined and the mean number of proliferating cells, the total number of cells, and the degree of mesangiolysis was determined. Glomerular cross-sections containing only a minor portion of the glomerular tuft (< 20 discrete capillary segments/cross-section) were not included in the analysis. Cellularity was expressed as the total number of nuclei per glomerular cross-section in tissue sections stained with the periodic acid Schiff reagent. Proliferation was expressed as the number ofcells per glomerular cross-section that were positive for the proliferating cell nuclear antigen (PCNA)/cyclin as determined by immunocytochemistry (14) . PCNA/cyclin is an auxiliary protein to DNA polymerase-6 (17); expression is restricted to late GI, S, G2, and M phases of the cell cycle (18) . Mesangiolysis was graded semiquantitatively using the following scale (19) :
0 No mesangiolysis. 1 + Segmental mesangiolysis affecting occasional (< 25%) glomeruli.
2+ Focal (25-50%) involvement ofglomeruli with affected mesangial areas showing global lucency with occasional disruption; generally good preservation of the underlying mesangial stalk architecture.
3+ Most glomeruli affected with extensive disruption ofmesangial' areas, but with preservation ofthe underlying glomerular tuft architecture.
4+ Virtually all glomeruli affected, frequently with complete dissolution ofthe mesangial areas, usually in association with microaneurysm formation.
Complement depletion
Rats were depleted with cobra venom factor (CVF) (Naja naja kaounthia, Diamedix Corp., Miami, FL) (30 U) i.p. in three divided doses beginning 24 h before injection of ATS and then received an additional 10 U i.p. daily until sacrifice. Serum C3 levels were measured by radial immunodiffusion and a value of < 10% baseline was considered complement depleted ( 19) . We have recently demonstrated that CVF treatment does not affect circulating platelet counts or in vitro aggregation of platelets to ADP or collagen (19) .
Platelet depletion
Platelet depletion was performed with a goat anti-rat platelet IgG as previously described (14, 20) . Rats received an i.p. dose of 8 mg/100 g body weight with repeat doses of 2-3 mg/100 g given i.v. at 24-h intervals. Thrombocytopenia (platelet count < 25,000/mm3) was achieved in all rats at the time ofinjection ofATS and until sacrifice 3 d later. We have previously reported that platelet depletion ofrats with anti-Thy 1 GN does not affect glomerular deposition of anti-Thy 1 IgG, circulating leukocyte counts, or plasma CH50 titers relative to controls (14) .
Immunohistochemical staining for actin, desmin, vimentin, and the Proliferating Cell Nuclear Antigen (PCNA)/cyclin Sections of methyl Carnoy's fixed tissue were deparaffinized with Histoclear (National Diagnostics, Highland Park, NJ) and graded ethanols, blocked with 0.3% hydrogen peroxide and 0.1% sodium azide, and washed with PBS (138 mM NaCl, 2.7 mM KCI, 3.2 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.3) containing 0.1% BSA (Sigma Chemical Co., St. Louis, MO) and 0.01% Triton X-100. The tissue was then incubated with one of the primary murine monoclonal antibodies (see below), and subsequently processed using a strep-avidin-biotin immunoperoxidase method (21) with 3,3'-diaminobenzidine (with nickel chloride enhancement) as the chromogen. Sections were counterstained with methyl green.
A variety of murine monoclonal anti-actin antibodies were used for immunoperoxidase staining, including anti-aSM-1 (21) (gift of G. Gabbiani), CGA-7 (22), HHF-35 (23) , and C4 (24) (gift of J. Lessard). The specificities of these antibodies are shown in Table I . Desmin was detected with D33 (Dako Corp., Santa Barbara, CA), vimentin with murine monoclonal antibody M725 (Dako Corp.), and PCNA/cyclin with murine IgM monoclonal antibody 19A2 (American Biotech Inc., Plantation, FL) (25) . For all biopsies a negative control consisted of substituting the primary antibody with an irrelevant murine monoclonal antibody.
Tissue sections were also double labeled for both PCNA/cyclin and muscle actin. Sections were first stained for PCNA/cyclin with 19A2, a murine IgM monoclonal antibody, using an indirect immunogold procedure (Janssen Life Science Products, Piscataway, NJ) with a class- 
Routine histology
Tissue for light microscopy was fixed in methyl Carnoy's solution, dehydrated in graded ethanols, and embedded in paraffin. 3-,gm sections were stained with the periodic acid Schiff reagent. Tissue for transmission electron microscopy (EM) was processed as previously described (19) .
Immunoelectronmicroscopy (Immuno-EM)
Tissue was perfusion fixed with periodate-lysine-paraformaldehyde (PLP) (27) , then immersion fixed in PLP for 4 h, and transferred to PBS. After dehydration with graded ethanols, the tissue was incubated in LR white resin (Polysciences, Inc., Warrington, PA) and embedded in gelatin capsules, and cured overnight at 50°C. Thin sections were mounted on coated nickel grids, blocked with 10% normal goat serum, rinsed with PBS, incubated with HHF-35 or a control irrelevant monoclonal antibody overnight at 4°C, rinsed with PBS, followed by incubation with goat anti-mouse IgG conjugated to gold (10-nm particles) (Sigma Chemical Co.). Grids were treated with uranyl acetate and then examined using a Phillips 410 electron microscope.
Glomerular RNA preparation Rats were sacrificed under ether anesthesia and the kidneys removed, decapsulated, and glomeruli isolated by differential sieving (20) at 4°C using PBS prepared with diethyl pyrocarbonate (DEP)-treated water. Isolated glomeruli were lysed with acid guanidinium thiocyanate containing 2-mercaptoethanol and 10% sarcosyl, and extracted with phenol and chloroform-isoamyl alcohol according to the method of Chomczynski and Sacchi (28) . Contaminating DNA was removed by treatment with RQ1 DNase (Promega Biotec, Madison, WI) according to the manufacturer's instructions. The RNA was precipitated at -70°C with ethanol (2.5 vol) and redissolved in 10 mM Tris-HCl pH 7.4, 5 mM EDTA (TE buffer). - [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] ,g glomerular RNA was obtained per rat with a purity as assessed by OD26o/OD2so ratio of 1.7 or higher.
Gel electrophoresis and transfer to membranes
The RNA from each group of animals was pooled and aliquots were denatured with formamide, formaldehyde, and heat (65°C x 10 min) and electrophoresed through 1% agarose gels containing 2.2 M formaldehyde/0.2 M MOPS pH 7.0 (15 jg/lane as measured by OD260); transferred to a nylon filter (Zeta probe, Bio-Rad Laboratories, Inc., Richmond, CA) overnight by capillary blotting, and baked at 80°C for 2 h (29). Good resolution and integrity ofthe 28S and 18S ribosomal RNA bands was apparent when examined under UV light in the presence of ethidium bromide.
DNA probes and hybridization conditions
Two DNA probes were used: (a) a 1.3-kb Pst I fragment of bovine ,y-actin cDNA isolated from the plasmid pBA-1 (30) was used to detect the 2.1-kb transcripts of (B/y actin mRNA, and (b) an oligonucleotide (AGTGCTGTCCTCTTCTTCACACATA) complementary to a sequence unique to the human a-smooth muscle actin mRNA (31) was used to detect the 1.6-kb transcript of rat a-smooth muscle actin. The B/'y-actin probe was labeled with (a-32P)-dCTP by random primer extension and the oligonucleotide probe was end-labeled with (y_32p)_ ATP and T4 polynucleotide kinase. The labeled oligomer was further purified by electrophoresis on a 15% polyacrylamide gel and elution from the gel slice into TE buffer.
For the general (#/y-actin probe, prehybridization was performed by incubating the membranes in a solution containing 5x SSPE (IX SSPE is 0.18 M NaCl, 0.01 M NaPO4, 0.001 M EDTA, pH 7.7), 5X Denhardt's solution, 50% formamide, 0.1% SDS, and 100 ,g denatured salmon sperm DNA for 2 h at 42°C, followed by addition of32P-labeled probe (final concentration, 106 cpm/ml) and continued incubation overnight at 42°C. The membranes were then washed with 6x SSPE, 0.1% SDS three times at room temperature, followed by two washes in Ix SSPE, 0.1% SDS at 42°C. For the oligonucleotide probe, prehybridization was performed with 1% SDS, 5x SSC (Ix SSC is 0.15 M NaCl, 0.015 M Na citrate, pH 7.0), 50 mM Tris, pH 7.5, lx Denhardt's, and 20 ,ug/ml poly (A) at 42°C, followed by hybridization in the same buffer, to which 2 x 106 cpm/ml of 32P-labeled oligonucleotide probe had been added, for an additional 16 h at 42°C. Washes were in I x SSC, 0.1 % SDS at room temperature, and 0.2x SSC, 0.1% SDS at 37°C, at 40°C, and at 42°C, each for 10 min. After the washes, filters were exposed to Kodak X-O MAT film with enhancing screens at -70°C for 30.5 and 22.5 h, and the resulting autoradiograms read by linear densitometry. 
Statistical analysis
Values are expressed as the mean±SE. The statistical analysis of the multiple groups was performed using the one-way analysis of variance (ANOVA). Simultaneous multiple comparisons between groups were performed with modified t statistics using Bonferroni's method (32) .
Results
Description of mesangial proliferative GN due to anti-Thy I antibody (A TS) and the effect ofplatelet and complement deple- tion. The injection of ATS into normal rats resulted in acute mesangiolysis that was associated with a decrease in total glomerular cellularity at 24 h (i.e., day 1) (Table II) . This was followed by a rebound in total glomerular cellularity at 3 and 5 d in association with actively proliferating (i.e., PCNA/cyclin +) cells (Table II) . Previous studies have demonstrated that the majority (i.e., > 80%) ofthese proliferating cells are glomerular in origin (14) . An important role for complement (13) and for platelets (14) in anti-Thy 1 GN was confirmed in this study (Table II) . Complement depletion completely prevented both mesangiolysis and cell proliferation (Table II) . In contrast, platelet depletion (platelet counts < 25,000/mm3) did not prevent mesangiolysis, and reduced but did not abolish cell proliferation (Table II).
Expression of a-smooth muscle actin in anti-Thy I GN. Tissues were initially stained by immunoperoxidase with HHF-35, a monoclonal antibody that recognizes the muscle actin isoforms (Table I) . Normal glomeruli do not express detectable amounts ofmuscle actin, although actin can be readily observed in the afferent and efferent arterioles (Fig. 1 ). In contrast, substantial amounts of muscle actin could be demonstrated in glomeruli of rats with anti-Thy 1 GN (Fig. 1) . Actin expression in glomeruli was first noted 3 d after injection of ATS, and often appeared to radiate out from the hilus along the mesangial stalks. At day 5 muscle actin expression was extensive, often concentrated in a "nodular" pattern in mesangial areas, and occasionally involving the entire glomerulus (Fig. 1) . The expression of muscle actin was transient, being barely detectable at day 14, and absent by day 21 (n = 2).
To further clarify the type ofactin being expressed, sections were stained with three other anti-actin antibodies (Table I) (Fig. 2) . C4, an actin antibody that recognizes all six actin isoforms, demonstrated a similar staining pattern as HHF-35, with the exception that small amounts of actin (1+) could be detected in normal glomeruli in mesangial regions. CGA-7, a monoclonal antibody that recognizes a and y smooth muscle actins, resulted in negative glomerular staining despite a very positive staining of blood vessels (Fig. 2) . However, CGA-7 does not bind all cells that bear a-smooth muscle actin (22, 23), possibly because it may recognize a smooth muscle specificepitope that has undergone a posttranslational modification. This was further suggested in this study by the observation that anti-asm-1, a monoclonal antibody specific for a-smooth muscle actin, gave identical results as HHF-35 (Fig. 2) .
Ultrastructural studies were performed to confirm the light microscopy findings. Transmission EM in a rat with anti-Thy 1 GN thus confirming the presence of muscle actin (Fig. 3) . Normal glomeruli had substantially less HHF-35 reactivity in mesangial areas, although it was of interest that both normal and diseased glomeruli had reactivity of HHF-35 within the epithelial cell foot processes (Fig. 3 C) . The density of gold particles within the foot processes of diseased and normal animals appeared equivalent. Specificity of the immuno-EM was shown by substituting an irrelevant control monoclonal antibody for HHF-35. a-Smooth muscle actin expression is associated with proliferation. To determine if the muscle actin expression was associated with cell proliferation, double-labeling of tissue sections was performed using HHF-35 (muscle actin marker) and 19A2 (anti-PCNA/cyclin antibody). The double-labeled preparations unequivocally demonstrated that the majority ofproliferating cells were also expressing muscle actin (Fig. 4) .
Furthermore, measures to prevent or reduce cell proliferation, such as complement depletion and platelet depletion, respectively, were associated with either a prevention or reduction in muscle actin staining (Table III) (Fig. 5) . Similar degrees of reduction in staining pattern were noted with the monoclonal antibody specific for a-smooth muscle actin (i.e., antia-sm-l).
Actin gene expression in anti-Thy I GN. Northern analysis was performed with glomerular RNA from normal rats and rats with anti-Thy 1 GN to determine ifthe expression ofactin mRNA paralleled the immunohistochemical findings. Hybridization with the general actin probe, pBA 1, demonstrated that the 2.1-kb transcripts for 13/y actin mRNAs were markedly elevated in rat glomerular RNA collected 3 and 5 d after induction of anti-Thy 1 GN (Fig. 6 A) . On prolonged exposure with the general actin probe there appeared to be a second band of 1.6 kb consistent with a actin (data not shown). To determine ifthis band represented a-smooth muscle actin mRNA, a separate hybridization was performed with an oligonucleotide probe complementary to a sequence unique to human asmooth muscle actin mRNA. Hybridization with the oligonucleotide probe proved the 1.6-kb transcript to be a-smooth muscle actin, and demonstrated a similar temporal pattern as that observed for 13/y actin mRNA (Fig. 6 B) . At day 3 expression was maximal with an 11-fold increase in (3/y actin mRNA and a 6.5-fold increase in a-smooth muscle actin mRNA as assessed by linear densitometry (after normalizing for the quantity of 28S RNA in each lane) (Table III) . Both the a and #/-y actin mRNA expression were markedly reduced in complement-depleted and platelet-depleted rats with anti-Thy 1 GN (Fig. 6 vimentin. In normal rat glomeruli desmin was distributed primarily in a mesangial pattern (Fig. 7 a) . Occasional podocytes were also desmin-positive. After injection of ATS, there was a loss of desmin staining at 24 h, in association with the severe mesangiolysis. However, by day 3 mesangial staining for desmin was restored, and by day 5 a marked expansion ofdesmin was noted in areas of mesangial hypercellularity (Fig. 7 b) . Vimentin, in contrast to desmin, was present primarily in glomerular visceral epithelial cells; staining of mesangial cells and glomerular endothelial cells was minimal in normal rat glomeruli (Fig. 7 c) . In anti-Thy 1 GN vimentin staining was not altered until day 3 when it was focally increased in areas of mesangial hypercellularity. By day 5 the mesangial staining for vimentin was extensive (Fig. 7 d) .
Rats with anti-Thy I GN that were complement-depleted had desmin and vimentin staining patterns that were identical to that seen in normal rats. In contrast, platelet-depleted rats with anti-Thy I GN had normal vimentin staining of the glomerular visceral epithelial cells but only minimal desmin staining in mesangial regions. The lack of desmin staining in platelet-depleted rats was likely due to the persistent mesangiolysis rather than to direct effects of the anti-platelet IgG on the glomerulus as desmin staining was not altered in rats without GN (n = 4) that were given equivalent doses of anti-platelet IgG. Expression of a-smooth muscle actin in other glomerular diseases. Studies were performed to determine if muscle actins were expressed in other experimental glomerular diseases (Table IV). Immunohistochemical studies ofglomeruli in diseases associated with glomerular epithelial cell injury (i.e., passive Heymann's nephritis and aminonucleoside nephrosis) or glomerular basement membrane injury (i.e., anti-GBM GN) were negative for muscle actin. However, in the model of mesangial cell injury induced with Habu snake venom, glomeruli that demonstrated mesangial hypercellularity expressed smooth muscle actin. Muscle actin could also be detected in mesangial areas in the immune complex GN due to concanavalin A (con A) and anti-con A antibody, which is a model ofboth endothelial and mesangial cell injury. Discussion a-Smooth muscle actin is one of six closely-related actin isoforms (see Table I ). Unlike the (3 and 'y cytoplasmic actins, which are present in most cells, the presence of a-smooth muscle actin has been interpreted as a marker for smooth musclederived tissues (34) . In adult vascular smooth muscle, asmooth muscle actin is the predominant actin isoform (35) and has been proposed to have a major contractile function (36). Recently, this actin isoform has also been observed in myoepithelial cells, myofibroblasts in pathologic tissues, and in some skeletal muscle tumors (37, 38) . a-Smooth muscle actin has also been reported in chicken embryo fibroblasts and certain rodent fibroblast cell lines (39, 40) , suggesting that these cell The current study demonstrates that expression of asmooth muscle actin is upregulated in mesangial proliferative GN in the rat induced with anti-Thy 1 antibody. It is known that smooth muscle actin content may be controlled either at the level of transcription, translation, or protein turnover (41) . In this study, Northern analysis of isolated glomerular RNA . , , J , , , . :
.., w.W, showed an increase in a-smooth muscle actin mRNA in rats with anti-Thy 1 GN, peaking at day 3; this corresponded with the appearance of a-smooth muscle actin-positive cells that were greatest at day 5. We also observed a marked increase in #/T actin mRNA in diseased rats at days 3 (2, 3) . In cell culture, mesangial cells are morphologically similar to smooth muscle cells and express the musclespecific marker desmin (42) , as well as the nonspecific isoforms of myosin (3) and actin (42) . It is interesting that mesangial cells in culture show only weak immunostaining for smooth muscle actin (with HHF-35) despite strong staining with the pan-actin antibody (i.e., C4) (data not shown). Mesangial cells in vitro will also contract in response to various stimuli, although several minutes are required to demonstrate this effect (2, 3) . It is tempting to speculate that the slow onset ofcontraction may relate to only low levels ofsmooth muscle actin being constitutively expressed by mesangial cells in culture.
Studies in vivo have also demonstrated that mesangial cells are continuous with and ultrastructurally similar to the lacis cells and smooth muscle cells ofthe juxtaglomerular apparatus (43) . Mesangial regions of human glomeruli also stain with an antimyosin antibody (44, 45) , although there is not any evidence that this is specific for smooth muscle cells. Our studies demonstrate that under pathological conditions (i.e., with mesangial proliferation) mesangial cells express a-smooth muscle actin and desmin, both muscle specific markers, thus providing additional evidence for a phenotypic similarity between smooth muscle cells and mesangial cells.
The second major finding in these experiments was the demonstration that smooth muscle actin expression was associated with active cellular proliferation. Cells bearing smooth muscle actin were not observed by light microscopy until day 3 ofanti-Thy I GN, at a time when cellular proliferation was first observed. Double immunolabeling demonstrated that the proliferating cells were those that expressed muscle actin. Finally, prevention or reduction of the number of proliferating cells within the mesangium by complement depletion or platelet depletion, respectively, significantly reduced the number of cells expressing a-smooth muscle actin in the glomerulus, and the amount of a-smooth muscle actin and #/'y actin mRNA in glomerular RNA extracts.
In vascular smooth muscle, proliferation has been correlated with a loss ofa-smooth muscle actin, and with an increase in ,B-actin synthesis (46, 47) . This phenotypic change in actin expression is not an absolute prerequisite for cell proliferation (48) , but does appear to be coupled to the cell cycle, occurring late in the GO/G 1 phase (48, 49) . Thus, the mesangial cell may be relatively unique in that a-smooth muscle actin is expressed during proliferation as opposed to being repressed.
An alternative hypothesis is that the appearance of cells bearing a smooth muscle phenotype in mesangial locations represents smooth muscle cells that migrate into the glomerulus, proliferate, eventually lose a-smooth muscle actin and "differentiate" into true mesangial cells. This would be more consistent with the known propensity for smooth muscle cells to lose a-actin with proliferation. This would also be consistent with our understanding ofthe developing nephron, in which mesangial cells have been proposed to originate from endothelial/ mesangial cell precursors that invade the nephrogenic mesenchyme (50) . This is further supported by recent in situ hybridization studies in fetal kidneys that demonstrate that renin-producing cells can be observed extending from thejuxtaglomerular apparatus into the mesangium (51) . The observation that platelets may mediate smooth muscle migration into injured intima of the carotid after balloon catheter injury (52) is consistent with the hypothesis that platelets may stimulate smooth muscle cell migration into glomeruli. The mechanism of cellular migration may involve platelet-derived growth factor, as this factor has been reported to be chemotactic for both smooth muscle cells (53) and mesangial cells (54) .
We also examined the distribution of the intermediate filament proteins, desmin and vimentin, in normal and diseased glomeruli. Desmin has been regarded as a muscle differentiation marker (55) and has been reported to be present in vivo in mesangial cells of rats (56, 57) but not man (56, 58 has also been reported to be either present (56), variably expressed (59), or absent (57) in vivo in glomerular epithelial cells in the rat. We noted that desmin was localized primarily in a mesangial distribution. However, occasional glomerularepithelial cells were also desmin-positive. In mesangial proliferative GN a marked increase in desmin in mesangial areas was noted; this was prevented in platelet-or complement-depleted rats in which proliferation was largely inhibited. foot processes. This is consistent with a previous study in which both actin and meromyosin were localized by immuno-EM to the podocyte foot processes (using polyclonal antibodies) (60) and also with the observation that the podocyte foot processes are rich in microfilaments (61) . The glomerular epithelial cell originates from nephrogenic mesenchyme but develops epithelial cell features via an inductive process (62 (16) and con A/anti-con A immune complex GN (20) , were associated with smooth muscle actin expression by cells within mesangial regions. This suggests that smooth muscle actin expression may be a marker for mesangial cell injury in the rat.
The importance of the phenotypic change by mesangial cells in GN remains unknown. It is possible that these alterations may result in a mesangial cell with greater contractility.
The concept that mesangial cell contraction may occur in GN is supported by the observation that several inflammatory substances known to mediate mesangial cell contraction in vitro (2) are likely to be present in GN, including platelet activating factor, thromboxane, and PDGF. Thus, it is possible that the acquisition ofa smooth muscle phenotype may enable the mesangial cell to modulate and perhaps to contribute to the altered glomerular hemodynamics and pressures that are known to occur in GN.
